Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, ...
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...
The CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems represent the next generation of the company’s CFX Real-Time PCR Systems that are used in research and genomic testing as well as in pathogen ...
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Duet Real-Time PCR System to support researchers in ...
Use the most precise and sensitive PCR solution for absolute quantification of target DNA or RNA molecules. The system includes a QX200 droplet generator and reader, dedicated computer, QuantaSoft ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of four new Droplet Digital™ PCR (ddPCR™) platforms. The newly introduced instruments include Bio-Rad’s QX Continuum™ ddPCR ...
QCL is an independent food testing lab that employs over 200 professional scientists and support personnel and operates eight facilities in Pennsylvania, New Jersey, and Delaware. The iQ-Check Prep ...
Bio-Rad Laboratories said it is acquiring AbD Serotec from parent company MorphoSys for €53 million ($69.7 million). The deal adds Serotec’s more than 15,000 antibodies, kits, and accessories to ...
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback